Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis

NCT00630656 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Sepsis

Interventions

DRUG: Talactoferrin alfa
DRUG: Placebo

Sponsor

Agennix